Matching slides 79,264
Current window 71,371-71,400
Pages 2,643
Rows per page 30
Component: Metricclear collectionreset all

Component

71,371-71,400 of 79,264

filter-aware
01
Slide 1
The slide uses a 'villain' framing to justify a short position, citing specific financial metrics and legal/governance concerns.ADOMANI (ADOM) · White Diamond Research
Research note Short seller Beat · Villain CritiqueLoop · Aha Moment1 hit
08
The text serves as a short-seller research note highlighting a discrepancy between company guidance and financial filings.ADOMANI (ADOM) · White Diamond Research
Research note Short seller Beat · Expose Contradiction1 hit
09
The slide highlights a massive discrepancy between historical revenue (near zero) and projected revenue ($309M in 2018).ADOMANI (ADOM) · White Diamond Research
Research note Short seller Beat · Expose Contradiction1 hit
14
The slide uses a short-seller report and SEC filings to argue that the company's valuation is artificially inflated due to restricted insider selling.ADOMANI (ADOM) · White Diamond Research
Research note Short seller Beat · Villain CritiqueLoop · Cost Of Inaction1 hit
15
The slide provides a critical assessment of share structure, focusing on potential selling pressure from warrants and options.ADOMANI (ADOM) · White Diamond Research
Research note Short seller Beat · Villain CritiqueLoop · Cost Of Inaction1 hit
01
Slide 1
This is a short-seller research note cover page.Accelerate Diagnostics (AXDX) · White Diamond Research
Research note Short seller 1 hit
05
The slide uses external citations (FDA approval, peer-reviewed article, ECCMID poster) to build a negative case against the subject technology.Accelerate Diagnostics (AXDX) · White Diamond Research
Research note Short seller Beat · Problem (Identify pain)Loop · Zoom In1 hit
13
The slide uses a screenshot of a company presentation to frame a contradiction, then provides a textual rebuttal based on study methodology.Accelerate Diagnostics (AXDX) · White Diamond Research
Research note Short seller Beat · Agitate (Make it worse)1 hit
15
The slide uses a timeline diagram and a comparison table to challenge AXDX's claimed 75% time advantage.Accelerate Diagnostics (AXDX) · White Diamond Research
Research note Short seller Beat · Agitate (Make it worse)1 hit
17
The slide explains the methodology for deriving average instrument revenue percentages from disparate analyst reports.Accelerate Diagnostics (AXDX) · White Diamond Research
Research note Short seller 1 hit
18
The table reconstructs cumulative totals based on the provided bar chart data.Accelerate Diagnostics (AXDX) · White Diamond Research
Research note Short seller 1 hit
21
The slide uses a data table to expose a discrepancy between management's claims and the analyst's model.Accelerate Diagnostics (AXDX) · White Diamond Research
Research note Short seller 1 hit
22
The chart shows a clear downward trend in reagent revenue per system from Q4 2017 to Q2 2019.Accelerate Diagnostics (AXDX) · White Diamond Research
Research note Short seller 1 hit
31
The slide uses a skeptical tone to challenge management's guidance, citing specific quarterly placement figures (133, 75, 55) to highlight a downward trend.Accelerate Diagnostics (AXDX) · White Diamond Research
Research note Short seller Beat · Solution (Provide relief)Loop · Cost Of Inaction1 hit
33
The slide contrasts positive clinical trial data (PHENOMENON study) with negative market sentiment from a sell-side analyst survey.Accelerate Diagnostics (AXDX) · White Diamond Research
Research note Short seller Beat · Solution (Provide relief)Loop · Cost Of Inaction1 hit
36
The table compares T2 Biosystems (implied) vs Accelerate Diagnostics (AXDX).Accelerate Diagnostics (AXDX) · White Diamond Research
Research note Short seller Beat · Solution (Provide relief)Loop · So What Cascade1 hit
37
The slide uses a narrative-driven argument to discredit the 'insider buying' signal often used by retail investors.Accelerate Diagnostics (AXDX) · White Diamond Research
Research note Short seller Beat · Solution (Provide relief)Loop · So What Cascade1 hit
39
The slide uses a narrative of corporate governance and executive hierarchy to predict a 'reset' of market guidance.Accelerate Diagnostics (AXDX) · White Diamond Research
Research note Short seller Beat · Solution (Provide relief)Loop · So What Cascade1 hit
40
Research note by White Diamond Research, page 40.Accelerate Diagnostics (AXDX) · White Diamond Research
Research note Short seller Beat · Solution (Provide relief)Loop · So What Cascade1 hit
41
This is a short-seller research note.Accelerate Diagnostics (AXDX) · White Diamond Research
Research note Short seller Beat · Solution (Provide relief)1 hit
13
The slide uses two tables to demonstrate that management's bonus-linked AFFO is artificially high due to accounting choices, resulting in millions in payouts that would not occur under industry-standard calculations.CTO Realty Growth, Inc. (CTO) · Wolfpack Research
Research note Short seller Beat · The Struggle1 hit
14
The slide uses a table to recalculate AFFO by stripping out intangible asset amortization, highlighting a growing delta over three years.CTO Realty Growth, Inc. (CTO) · Wolfpack Research
Research note Short seller Beat · The Struggle1 hit
15
Includes two tables showing financial adjustments for Armada Hoffler Properties and City Office REIT.CTO Realty Growth, Inc. (CTO) · Wolfpack Research
Research note Short seller Beat · The Victory1 hit
16
The slide highlights specific line items related to capital expenditures (CapEx) across three different REITs using red boxes.CTO Realty Growth, Inc. (CTO) · Wolfpack Research
Research note Short seller Beat · The Victory1 hit
17
The slide highlights capital expenditure adjustments in red boxes for each peer.CTO Realty Growth, Inc. (CTO) · Wolfpack Research
Research note Short seller Beat · The Victory1 hit
22
The slide uses a waterfall-style logic to illustrate capital destruction.CTO Realty Growth, Inc. (CTO) · Wolfpack Research
Research note Short seller 1 hit
19
The diagram shows ownership links between The Debtor, Leshi ZX Tianjin, Leshi Investment, Leshi ZX Commerce, LeSoar, and Innovation Era, with Mr. Lyu identified as a key figure.Faraday Future Intelligent Electric Inc. (FFAI) · Wolfpack Research
Research note Short seller Beat · The VictoryLoop · Cost Of Inaction1 hit
20
The slide uses investigative narrative to link various entities to YT's personal bankruptcy and potential fraud.Faraday Future Intelligent Electric Inc. (FFAI) · Wolfpack Research
Research note Short seller Beat · The Victory1 hit
01
Slide 1
Includes detailed financial tables for revenue and EPS projections, and company profile metrics.Atomera Inc. (ATOM) · Richard Shannon
Research note Short seller Beat · AttentionLoop · Cost Of Inaction1 hit
02
Includes a qualitative discussion on M&A potential for ATOM.Atomera Inc. (ATOM) · Richard Shannon
Research note Short seller Beat · InterestLoop · Cost Of Inaction1 hit